<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87323">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01873651</url>
  </required_header>
  <id_info>
    <org_study_id>Delta III</org_study_id>
    <nct_id>NCT01873651</nct_id>
  </id_info>
  <brief_title>Longterm Outcome of the Delta III Inverse Prosthesis</brief_title>
  <official_title>The Reverse Delta III Total Shoulder Prosthesis - Longerm Results in 98 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Schulthess Klinik</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Schulthess Klinik</source>
  <oversight_info>
    <authority>Switzerland: Swissmedic</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to describe the results after &gt; 10 years due to a prosthesis
      implant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to measure the gain of the benefit in function an painreduction
      which the patient yields with this type of prosthesis in a longterm (&gt; 10 years )outcome.
      Additionally the long-term results will be compared with the mid-term results and the
      literature. Furthermore the complications since the mid-term measurement time point will be
      determined.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Constant Murley Score</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>cASES</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pASES</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DASH-Questionannaire</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SPADI</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>x-ray (Sperling Classification)</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>x-ray (Sirveaux Classification)</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description of the glenoid</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Description of the situation:
e.g.
any dissociation of the gleonid
any migration of the glenoid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description of the stem</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Description of the situation:
e.g.
- change of the position</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Rotator Cuff Arthropathie</condition>
  <arm_group>
    <arm_group_label>Delta III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation of a Delta III Prosthesis</intervention_name>
    <arm_group_label>Delta III</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  implantation of a Delta III - prothesis

          -  timeframe (Oct 1998 - Dec 2002)

          -  delta-pectoral approach

          -  written informed consent

        Exclusion Criteria:

          -  Implantation because of a revision

          -  Complaints, which make it difficult to follow instructions or even prevent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 7, 2013</lastchanged_date>
  <firstreceived_date>June 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Schulthess Klinik</investigator_affiliation>
    <investigator_full_name>Matthias Flury</investigator_full_name>
    <investigator_title>Principal Investigator (Department of Upper Extremity)</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
